Search Results

PNU 282987 10mg 10mg  | Purity Not Available

Adooq Bioscience

PNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.

More Information Supplier Page

Troxacitabine (SGX-145) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Troxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.

More Information Supplier Page

Troxacitabine (SGX-145) 25mg 25mg  | Purity Not Available

Adooq Bioscience

Troxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.

More Information Supplier Page

A 803467 25mg 25mg  | Purity Not Available

Adooq Bioscience

A 803467 is a selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively).

More Information Supplier Page

A 803467 50mg 50mg  | Purity Not Available

Adooq Bioscience

A 803467 is a selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively).

More Information Supplier Page

TAK-285 5mg 5mg  | Purity Not Available

Adooq Bioscience

TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).

More Information Supplier Page

TAK-285 25mg 25mg  | Purity Not Available

Adooq Bioscience

TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).

More Information Supplier Page

TAK-285 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).

More Information Supplier Page

TAK-285 10mg 10mg  | Purity Not Available

Adooq Bioscience

TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).

More Information Supplier Page